The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
The FBXW7-SHOC2-Raptor Axis Controls the Cross-Talks between the RAS-ERK and mTORC1 Signaling Pathways
Published version of a preprint
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“AMPK inhibits MTORC1 by phosphorylating and activating TSC2 [687], as well as by phosphorylating the MTOR binding partner RPTOR [688].”
From Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 (2021) · cites this paper as [687]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RING Domain E3 Ubiquitin Ligases
Deshaies, R. J., & Joazeiro, C. A. P. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.101807.093809 · Cited by 2,679
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Soucy, T. A., Smith, P. G., Milhollen, M. A., Berger, A. J., Gavin, J. M., Adhikari, S., Brownell, J. E., Burke, K. E., Cardin, D. P., Critchley, S., et al. (2009) · Nature · doi:10.1038/nature07884 · Cited by 1,990
mTOR and cancer: insights into a complex relationship
Sabatini, D. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1974 · Cited by 1,322
Welcker, M., & Clurman, B. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2290 · Cited by 1,084
FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt
Pei, H., Li, L., Fridley, B. L., Jenkins, G. D., Kalari, K. R., Lingle, W., Petersen, G., Lou, Z., & Wang, L. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.07.016 · Cited by 709
ERK1/2 Phosphorylate Raptor to Promote Ras-dependent Activation of mTOR Complex 1 (mTORC1)
Carriere, A., Romeo, Y., Acosta-Jaquez, H. A., Moreau, J., Bonneil, E., Thibault, P., Fingar, D. C., & Roux, P. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.159046 · Cited by 268
Rodriguez-Viciana, P., Oses-Prieto, J., Burlingame, A., Fried, M., & McCormick, F. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.027 · Cited by 215
Flagged first, then by citations
Research works printed but not linked: 46
- Badea, 2008, Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia, Hepatogastroenterology, 55, 2016
- Berger, 2017, Targeted deep sequencing of circulating tumor DNA in metastatic pancreatic cancer, Oncotarget, 9, 2076, 10.18632/oncotarget.23330 · DOI
- Bernis, 2007, Pin1 stabilizes Emi1 during G2 phase by preventing its association with SCF(betatrcp), EMBO Rep., 8, 91, 10.1038/sj.embor.7400853 · DOI
- Cardenas, 1999, The TOR signaling cascade regulates gene expression in response to nutrients, Genes Dev., 13, 3271, 10.1101/gad.13.24.3271 · DOI
- Carrière, 2008, Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation, Curr. Biol., 18, 1269, 10.1016/j.cub.2008.07.078 · DOI
- Dai, 2006, Erbin inhibits RAF activation by disrupting the sur-8-Ras-Raf complex, J. Biol. Chem., 281, 927, 10.1074/jbc.M507360200 · DOI
- Fukushima, 2012, SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction, Cell Rep., 1, 434, 10.1016/j.celrep.2012.04.002 · DOI
- Gao, 2014, Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer, Oncotarget, 5, 3444, 10.18632/oncotarget.1813 · DOI
- Gu, 2007, SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB, J. Cell Biol., 178, 1009, 10.1083/jcb.200612067 · DOI
- Guertin, 2007, Defining the role of mTOR in cancer, Cancer Cell, 12, 9, 10.1016/j.ccr.2007.05.008 · DOI · Paper page
- Guertin, 2006, Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1, Dev. Cell, 11, 859, 10.1016/j.devcel.2006.10.007 · DOI
- He, 2017, HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion, Oncotarget, 8, 20165, 10.18632/oncotarget.15529 · DOI
- Inuzuka, 2011, SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction, Nature, 471, 104, 10.1038/nature09732 · DOI
- Jang, 2014, HUWE1 is a molecular link controlling RAF-1 activity supported by the Shoc2 scaffold, Mol. Cell. Biol., 34, 3579, 10.1128/MCB.00811-14 · DOI
- Jang, 2015, Spatial control of Shoc2-scaffold-mediated ERK1/2 signaling requires remodeling activity of the ATPase PSMC5, J. Cell Sci., 128, 4428
- Jeoung, 2013, Functional Integration of the Conserved Domains of Shoc2 Scaffold, PLoS One, 8, e66067, 10.1371/journal.pone.0066067 · DOI
- Jeoung, 2016, Shoc2-tranduced ERK1/2 motility signals--Novel insights from functional genomics, Cell. Signal., 28, 448, 10.1016/j.cellsig.2016.02.005 · DOI
- Ji, 2015, ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer, Cell Res., 25, 561, 10.1038/cr.2015.30 · DOI
- Jung, 2010, mTOR regulation of autophagy, FEBS Lett., 584, 1287, 10.1016/j.febslet.2010.01.017 · DOI · Paper page
- Kaduwal, 2015, Sur8/Shoc2 promotes cell motility and metastasis through activation of Ras-PI3K signaling, Oncotarget, 6, 33091, 10.18632/oncotarget.5173 · DOI
- Kelley, 2015, The Phyre2 web portal for protein modeling, prediction and analysis, Nat. Protoc., 10, 845, 10.1038/nprot.2015.053 · DOI · Paper page
- Koepp, 2001, Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase, Science, 294, 173, 10.1126/science.1065203 · DOI
- Kwon, 2012, Pten regulates Aurora-A and cooperates with Fbxw7 in modulating radiation-induced tumor development, Mol. Cancer Res., 10, 834, 10.1158/1541-7786.MCR-12-0025 · DOI
- Levine, 2004, Development by self-digestion: molecular mechanisms and biological functions of autophagy, Dev. Cell, 6, 463, 10.1016/S1534-5807(04)00099-1 · DOI
- Li, 2000, The leucine-rich repeat protein SUR-8 enhances MAP kinase activation and forms a complex with Ras and Raf, Genes Dev., 14, 895, 10.1101/gad.14.8.895 · DOI · Paper page
- Margottin-Goguet, 2003, Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase, Dev. Cell, 4, 813, 10.1016/S1534-5807(03)00153-9 · DOI
- Mizushima, 2010, Methods in mammalian autophagy research, Cell, 140, 313, 10.1016/j.cell.2010.01.028 · DOI · Paper page
- Narita, 2009, Autophagy facilitates oncogene-induced senescence, Autophagy, 5, 1046, 10.4161/auto.5.7.9444 · DOI
- O’Neil, 2007, FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors, J. Exp. Med., 204, 1813, 10.1084/jem.20070876 · DOI
- Selfors, 1998, soc-2 encodes a leucine-rich repeat protein implicated in fibroblast growth factor receptor signaling, Proc. Natl. Acad. Sci. USA, 95, 6903, 10.1073/pnas.95.12.6903 · DOI
- Shintani, 2004, Autophagy in health and disease: a double-edged sword, Science, 306, 990, 10.1126/science.1099993 · DOI
- Sieburth, 1998, SUR-8, a conserved Ras-binding protein with leucine-rich repeats, positively regulates Ras-mediated signaling in C. elegans, Cell, 94, 119, 10.1016/S0092-8674(00)81227-1 · DOI · Paper page
- Tan, 2011, SAG/RBX2/ROC2 E3 ubiquitin ligase is essential for vascular and neural development by targeting NF1 for degradation, Dev. Cell, 21, 1062, 10.1016/j.devcel.2011.09.014 · DOI
- Wang, 2012, Tumor suppressor functions of FBW7 in cancer development and progression, FEBS Lett., 586, 1409, 10.1016/j.febslet.2012.03.017 · DOI
- Wang, 2014, Roles of F-box proteins in cancer, Nat. Rev. Cancer, 14, 233, 10.1038/nrc3700 · DOI
- Wang, 2016, The emerging roles of F-box proteins in pancreatic tumorigenesis, Semin. Cancer Biol., 36, 88, 10.1016/j.semcancer.2015.09.004 · DOI
- Wei, 2005, The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase, Cancer Cell, 8, 25, 10.1016/j.ccr.2005.06.005 · DOI · Paper page
- Welcker, 2004, The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation, Proc. Natl. Acad. Sci. USA, 101, 9085, 10.1073/pnas.0402770101 · DOI
- Wertz, 2011, Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7, Nature, 471, 110, 10.1038/nature09779 · DOI
- Xie, 2015, Erbin is a novel substrate of the Sag-βTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis, J. Cell Biol., 209, 721, 10.1083/jcb.201411104 · DOI
- Xu, 2017, The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor, Nat. Commun., 8, 14002, 10.1038/ncomms14002 · DOI
- Yada, 2004, Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7, EMBO J., 23, 2116, 10.1038/sj.emboj.7600217 · DOI
- Young, 2013, An MRAS, SHOC2, and SCRIB complex coordinates ERK pathway activation with polarity and tumorigenic growth, Mol. Cell, 52, 679, 10.1016/j.molcel.2013.10.004 · DOI
- Zhang, 2016, FBXW7 Facilitates Nonhomologous End-Joining via K63-Linked Polyubiquitylation of XRCC4, Mol. Cell, 61, 419, 10.1016/j.molcel.2015.12.010 · DOI
- Zhang, 2016, Fbxw7 Deletion Accelerates KrasG12D-Driven Pancreatic Tumorigenesis via Yap Accumulation, Neoplasia, 18, 666, 10.1016/j.neo.2016.08.009 · DOI
- Zhao, 2011, DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(βTrCP) E3 ubiquitin ligase and regulates survival and autophagy, Mol. Cell, 44, 304, 10.1016/j.molcel.2011.08.029 · DOI
Cited by
Sorted by citations
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
Self-citation
Metadata
- Authors
- Xie, C.-M., Tan, M., Lin, X.-T., Wu, D., Jiang, Y., Tan, Y., Li, H., Ma, Y., Xiong, X., & Sun, Y.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 26
- Issue
- 11
- Pages
- 3037-3050.e4
- ISSN
- 2211-1247
- PMC
- PMC6503676
- Cited by
- 49
- References
- 7
- Language
- en
- Licence
- Funders
- National Key R&D Program (2016YFA0501800)
- National Natural Science Foundation of China (81630076)
- NCI (CA171277, CA156744)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review